High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.

about

High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.

Item

http://www.wikidata.org/entity/Q48197501

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.

@en

High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.

@nl

type

Item

label

High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.

@en

High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.

@nl

prefLabel

High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.

@en

High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.

@nl

P1476

High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy.

@en

P2093

Alvaro Moreno-Aspita

http://www.w3.org/2001/XMLSchema#string

Caroline Harlow

http://www.w3.org/2001/XMLSchema#string

Jonathan Hoyne

http://www.w3.org/2001/XMLSchema#string

Joseph L Blackshear

http://www.w3.org/2001/XMLSchema#string

Marcia Dubin

http://www.w3.org/2001/XMLSchema#string

Pooja Advani

http://www.w3.org/2001/XMLSchema#string

Saranya Chumsri

http://www.w3.org/2001/XMLSchema#string

Shelly Brock

http://www.w3.org/2001/XMLSchema#string

Thomas Suter

http://www.w3.org/2001/XMLSchema#string

P2860

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy.

Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab

Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview.

Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.

Evaluation of ultrasensitive cardiac Troponin I levels in patients with breast cancer during chemotherapy.

Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients.

Acceptable cardiac safety profile of neoadjuvant 5-fluorouracil, epirubicin, cyclophosphamide and celecoxib (FEC-C) for breast cancer: a subanalysis of biomarkers for cardiac injury.

P304

334-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000477797

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28704807

http://www.w3.org/2001/XMLSchema#string